Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year.
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly’s Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Here's a roundup of top developments in the biotech space over the last 24 hours:
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 152 companies set new 52-week lows.
Goldman Sachs Downgrades Passage Bio to Neutral, Lowers Price Target to $6
Goldman Sachs analyst Madhu Kumar downgrades Passage Bio (NASDAQ:PASG) from Buy to Neutral and lowers the price target from $29 to $6.
Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year.
Passage Bio Announces Pipeline Expansion and Clinical Program Update
Exercised two additional options with University of Pennsylvania's Gene Therapy Program aligned with company's focus on CNS diseases with high unmet need
Huntington's disease, a fatal rare adult
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.